Full Text View
Tabular View
No Study Results Posted
Related Studies
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
This study has been terminated.
( Lack of financial support )
Study NCT00677287   Information provided by Tokyo University

First Received on May 12, 2008.   Last Updated on December 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Colon Cancer
Rectal Cancer
Additional conditions recognized in this trial
Colonic Neoplasms
Colorectal Neoplasms
Rectal Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
RNF43, TOMM34, VEGFR1 and VEGFR2
Sponsors listed in this trial
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services